CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) saw a large decline in short interest in the month of January. As of January 15th, there was short interest totaling 14,803 shares, a decline of 75.4% from the December 31st total of 60,091 shares. Based on an average trading volume of 1,035,303 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 1,035,303 shares, the days-to-cover ratio is currently 0.0 days.
CV Sciences Stock Up 5.2%
OTCMKTS CVSI traded up $0.00 on Wednesday, reaching $0.04. 84,410 shares of the stock traded hands, compared to its average volume of 489,178. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.21 and a current ratio of 1.07. The firm’s fifty day simple moving average is $0.04 and its 200 day simple moving average is $0.04. CV Sciences has a 12 month low of $0.02 and a 12 month high of $0.10.
CV Sciences Company Profile
CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.
Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.
Read More
- Five stocks we like better than CV Sciences
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- Buy this Gold Stock Before May 2026
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
